Top

Published in:

01-06-2011 | Original Article

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts

Authors: W. D. Leslie, C. Berger, L. Langsetmo, L. M. Lix, J. D. Adachi, D. A. Hanley, G. Ioannidis, R. G. Josse, C. S. Kovacs, T. Towheed, S. Kaiser, W. P. Olszynski, J. C. Prior, S. Jamal, N. Kreiger, D. Goltzman, Canadian Multicentre Osteoporosis Study (CaMos) Research Group

Published in: Osteoporosis International | Issue 6/2011

Abstract

Summary

A procedure for creating a simplified version of fracture risk assessment tool (FRAX®) is described. Calibration, fracture prediction, and concordance were compared with the full FRAX tool using two large, complementary Canadian datasets.

Introduction

The Canadian Association of Radiologists and Osteoporosis Canada (CAROC) system for fracture risk assessment is based upon sex, age, bone mineral density (BMD), prior fragility fracture, and glucocorticoid use. CAROC does not require computer or web access, and categorizes 10-year major osteoporotic fracture risk as low (<10%), moderate (10–20%), or high (>20%).

Methods

Basal CAROC fracture risk tables (by age, sex, and femoral neck BMD) were constructed from Canadian FRAX probabilities for major osteoporotic fractures (adjusted for prevalent clinical risk factors). We assessed categorization and fracture prediction with the updated CAROC system in the CaMos and Manitoba BMD cohorts.

Results

The new CAROC system demonstrated high concordance with the Canadian FRAX tool for risk category in both the CaMos and Manitoba cohorts (89% and 88%). Ten-year fracture outcomes in CaMos and Manitoba BMD cohorts showed good discrimination and calibration for both CAROC (6.1–6.5% in low-risk, 13.5–14.6% in moderate-risk, and 22.3–29.1% in high-risk individuals) and FRAX (6.1–6.6% in low-risk, 14.4–16.1% in moderate-risk, and 23.4–31.0% in high-risk individuals). Reclassification from the CAROC risk category to a different risk category under FRAX occurred in <5% for low-risk, 20–24% for moderate-risk, and 27–30% for high-risk individuals. Reclassified individuals had 10-year fracture outcomes that were still within or close to the original nominal-risk range..

Conclusion

The new CAROC system is well calibrated to the Canadian population and shows a high degree of concordance with the Canadian FRAX tool. The CAROC system provides s a simple alternative when it is not feasible to use the full Canadian FRAX tool.

Kanis JA, Melton LJ III, Christiansen C et al (1994) The diagnosis of osteoporosis [see comments]. J Bone Miner Res 9:1137–41PubMedCrossRef

Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–89PubMedCrossRef

Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467–75PubMedCrossRef

Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108–12PubMedCrossRef

Cranney A, Jamal SA, Tsang JF et al (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575–80PubMed

Langsetmo L, Goltzman D, Kovacs CS et al (2009) Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 24:1515–22PubMedCrossRef

Siminoski K, Leslie WD, Frame H et al (2007) Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom 10:120–3PubMedCrossRef

Kanis JA, Johnell O, Oden A et al (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–95PubMedCrossRef

Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–82PubMedCrossRef

10.

Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–9PubMedCrossRef

11.

Adachi JD, Olszynski WP, Hanley DA et al (2000) Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 29:228–51PubMedCrossRef

12.

Leslie WD, Tsang JF, Lix LM (2009) Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res 24:353–60PubMedCrossRef

13.

Leslie WD, Lix LM (2010) Simplified 10-year absolute fracture risk assessment: a comparison of men and women. J Clin Densitom 13:141–6PubMedCrossRef

14.

Leslie WD, O’Donnell S, Jean S et al (2009) Trends in hip fracture rates in Canada. JAMA 302:883–9PubMedCrossRef

15.

Kanis JA, Oden A, Johansson H et al (2009) FRAX and its applications to clinical practice. Bone 44:734–43PubMedCrossRef

16.

Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–46PubMedCrossRef

17.

Leslie WD, Lix D, Langsetmo L, et al. (2010) Construction of a FRAX model for the assessment of fracture probability in Canada and implications for treatment. Osteoporis Int (in press)

18.

Chen P, Krege JH, Adachi JD et al (2009) Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res 24:495–502PubMedCrossRef

19.

Kreiger N, Tenenhouse A, Joseph L et al (1999) Research notes: the Canadian Multicentre Osteoporosis Study (CaMos) - background, rationale, methods. Can J Aging 18:376–87CrossRef

20.

Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–97PubMedCrossRef

21.

Berger C, Langsetmo L, Joseph L et al (2009) Association between change in BMD and fragility fracture in women and men. J Bone Miner Res 24:361–70PubMedCrossRef

22.

Genant HK, Grampp S, Gluer CC et al (1994) Universal standardization for dual x-ray absorptiometry: Patient and phantom cross-calibration results. J Bone Miner Res 9:1503–14PubMedCrossRef

23.

Roos NP, Shapiro E (1999) Revisiting the manitoba centre for health policy and evaluation and its population-based health information system. Med Care 37:JS10–JS14PubMedCrossRef

24.

WHO Collaborating Centre for Drug Statistics Methodology (2005) Guidelines for ATC classification and DDD assignment. Norwegian Institute for Public Health, Oslo

25.

Kozyrskyj AL, Mustard CA (1998) Validation of an electronic, population-based prescription database. Ann Pharmacother 32:1152–7PubMedCrossRef

26.

Leslie WD, Tsang JF, Caetano PA et al (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92:77–81PubMedCrossRef

27.

Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–82PubMedCrossRef

28.

Leslie WD, MacWilliam L, Lix L et al (2005) A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 16:773–82PubMedCrossRef

29.

Leslie WD, Caetano PA, MacWilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30PubMedCrossRef

30.

Leslie WD (2006) The importance of spectrum bias on bone density monitoring in clinical practice. Bone 39:361–8PubMedCrossRef

31.

Janes H, Pepe MS, Gu W (2008) Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 149:751–60PubMed

32.

Siminoski K, Leslie WD, Frame H et al (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56:178–88PubMed

33.

Leslie WD, O’Donnell S, Lagace C et al (2009) Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 21:1317–1322PubMedCrossRef

34.

Kanis JA, Johnell O, De Laet C et al (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–44PubMedCrossRef

35.

Fraser L, Langsetmo L, Berger C et al (2010). Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporis Int (in press)

36.

Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX((R)) tool: Fracture prediction and model calibration. J Bone Miner Res. doi:10.1002/jbmr.123

Title: Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts
Authors: W. D. Leslie
C. Berger
L. Langsetmo
L. M. Lix
J. D. Adachi
D. A. Hanley
G. Ioannidis
R. G. Josse
C. S. Kovacs
T. Towheed
S. Kaiser
W. P. Olszynski
J. C. Prior
S. Jamal
N. Kreiger
D. Goltzman
Canadian Multicentre Osteoporosis Study (CaMos) Research Group
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 6/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-010-1445-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts

Abstract

Summary

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2011

Oral bisphosphonates and risk of ischemic stroke: a case–control study

Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates

The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats

Bone regeneration and limb lengthening

How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide